SSRIs
SSRIs is a pharmaceutical drug with 13 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
2
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder
Efficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive Disorder
A Multicentre Clinical Study
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen
Clinical Trials (13)
Post-Traumatic Growth Following Eye Movement Desensitization and Reprocessing Therapy Versus SSRIs in Patients With Post-Traumatic Stress Disorder
Efficacy of Dextromethorphan-Bupropion Versus SSRIs in the Treatment of Major Depressive Disorder
A Multicentre Clinical Study
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen
Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder
Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive Disorder
Intradermal Needle Therapy for Major Depressive Disorder
A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder
The Gut Microbiota in Obsessive-Compulsive Disorder
A Kynurenine Pathway-based Molecular Imaging Study of Individualized Diagnosis and Treatment for Major Depressive Disorder
Objective Diagnostic Markers and Personalized Intervention in MDD Patients
Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13